Download F M69 Antrag Amtsbestaetigung CPP eng

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
BASG/AGES
Traisengasse 5, A-1200 Wien
E-Mail: [email protected] *)
d
APPLICATION FOR A CERTIFICATE OF A PHARMACEUTICAL PRODUCT (CPP)
1 issue(s)
Applicant
Date of receipt (BASG Stamp)
Exact name of the pharmaceutical product
Existing marketing
authorisation/
Marketing authorisation
No
Application for
marketing
authorisation
submitted
Marketing
authorisation not
requested
**)
Marketing
authorisation not
required
BASG GZ
**)
Importing country
a) The marketing authorisation holder/applicant is manufacturer of the dosage form ***)
b) The marketing authorisation holder/applicant is only involved in labelling and/or packaging ***)
c) The marketing authorisation holder/applicant is not involved in manufacture of the dosage form/
packing/labelling ***)
d) The marketing authorisation holder/applicant is manufacturer of the dosage form and further
manufacturing sites for the finished dosage form may be involved ***)
e) The marketing authorisation holder/applicant is involved in manufacturing of the dosage form together
with further manufacturing sites ***)
For categories b, c, d and e: please state name and address of the manufacturer(s) of the
dosage form***)
In the CPP only active substances should
be stated
In the CPP active substances and excipients should be
stated
The medicinal product is actually on the
market in Austria
The medicinal product is actually not on the market in
Austria
If the applicant is different from the marketing authorisation holder: Declaration of consent is enclosed.
Remarks ****)
F_MEA_VIE_BBSG_M69_03
Gültig ab: 27.03.2015
1 von 2
BASG/AGES
Traisengasse 5, A-1200 Wien
E-Mail: [email protected] *)
d
APPLICATION FOR A CERTIFICATE OF A PHARMACEUTICAL PRODUCT (CPP)
Additional data
concerning the
pharmaceutical
product are enclosed
Place, date, contact person, phone/ext. and signature*)
*)
Submission by E-mail (preferred) or as paper, in no case by both ways! In case of submission
by E-Mail signature is not required.
**) Submission of composition is required!
***) Data confirming the statements (module 3.2.P.3.1 or other equivalent documents) are required
unless there is a documentation according to eCTD!
****) information about special requests (eg, appendix to the CPP, personal collection of the CPP )
F_MEA_VIE_BBSG_M69_03
Gültig ab: 27.03.2015
2 von 2
Related documents